Author: Emma Yasinski

Emma Yasinski

I am a freelance science and medical journalist, fascinated by how the scientific process leads to incredible discoveries, but also can lead to publication bias leaning toward positive findings and minimizing negatives. With a bachelor’s degree in neuroscience from Lafayette College and a Master’s in Science and Medical Journalism from Boston University, I’ve written about clinical trial transparency, organ donation, and basic molecular biology for publications like The Scientist, The Atlantic, Undark.org, Kaiser Health News, and more. At MedShadow, I research and write about the sometimes unexpected ways that medicines can affect us, and what we can do if and when it does.

You have cancer. If that wasn’t terrifying enough, you now face a litany of medical choices, treatments, and drugs. As you try to educate yourself about those options, you also have to weigh the unpredictable nature of their side effects. Unfortunately, the side effects listed on the drug’s label don’t tell us much about what it’s really like to take a drug. A new article published in Undark explains how and why the information patients get on side effects often seems to minimize that challenge that side effects can pose. The article uses cancer drugs as an example and is…

Read More

Do you wake up with stiffness and joint pain? Have you been wondering whether you’re injured, you’re developing arthritis or if you just need a good stretch? Even if you do have arthritis, diet and exercise may go a long way toward mitigating your symptoms. MedShadow explains. What Is Arthritis? There are more than 100 types of arthritis, according to the Center for Disease Control and Prevention (CDC), but one thing they all have in common is that any arthritis damages the cartilage in your joints. In some cases, only a single joint will be affected, whereas for others, the…

Read More

It took seven years for Madeline Shonka to be diagnosed with lupus. Unfortunately, her struggles didn’t end there.  The side effects of medications for lupus that her healthcare providers prescribed were often debilitating side effects, such as weight gain, rashes and even difficulty managing anger. Then, over time, her physicians tested different, better-suited treatments on Shonka. She found that certain new habits, like light exercise, made a big difference in her quality of life. She then founded Co-immunity, which hosts support groups for patients with chronic illnesses, so that they can share their experiences. What Is Lupus? Lupus is an…

Read More
FDA

If you watch television, you’ve likely seen the commercials for the JAK (Janus kinase) inhibitors Xeljanz and Rinvoq that make bold claims. Those ads depict men and women ziplining, moving large amounts of heavy soil, hauling furniture and riding ATVs. “The [misleading] message is that you don’t have to be limited in any way,” explains Terry Graedon, PhD, a medical anthropologist and co-host of The People’s Pharmacy. “I would say that the likelihood [is pretty slim] that this is a realistic goal for most people, much less women with rheumatoid arthritis,  especially if they are people whose condition has not…

Read More

A new chemotherapy drug promises to treat some patients with pediatric acute lymphoblastic leukemia (ALL) who have been unable to take the other two other chemo medicines because one can cause allergic reactions and the other is frequently in short supply.  This summer, the Food and Drug Administration (FDA) fast-tracked the approval of Rylaze, a newer version of the chemo drug Erwinaze to treat ALL (leukemia) , made by Jazz Pharmaceuticals, which was previously distributed Erwinaze. The agency approved Rylaze based on an ongoing Phase 2/3 trial of about 102 patients, with an average age of 10.  The rare disease…

Read More